Trials involving medicinal products licensed in any EU Member State if:
- they relate to the licensed range of indications, dosage and form; or
- they involve off-label use (such as in paediatrics and in oncology etc.) if this off-label use is established practice and supported by sufficient published evidence and/or guidelines.
